Elliott Dunn

Investment Stage

Focus Areas

About Investor

Elliott Dunn is an Associate at Brandon Capital, a venture capital manager focused on the life sciences sector, focusing on investments in Medical Devices, Pharmaceuticals, Education, BioTech, Health & Hospital Services, and Therapeutics at pre-seed and seed stages, with checks between $100K and $5.0M. He is a board observer of Amaroq Therapeutics and a director of Cadmus Animal Health and TamoRx. Prior to joining Brandon Capital, he project managed the research team at Blis Technologies Ltd, was a Commercialisation Analyst for Otago Innovation Ltd, and a Scientific Officer in pharmacology at the University of Otago. He chaired the Return On Science Biotech & Pharma and Otago Momentum Investment Committees. He holds a PhD in Stem Cell Biology from the University of Auckland and a Bachelor's and Master's in Immunology from the University of Otago.